UN
Rating #129
University Of Texas/texas Am Investment Managment
University Of Texas/texas Am Investment Managment
Portfolio value
Stocks
Performance
1 Year
+8.53%
Stock Holdings
$
%
1Y
3Y
5Y
10Y
University Of Texas/texas Am Investment Managment’s Portfolio: Q4 2025
Top10 stocks: 60.59% of the portfolio
University Of Texas/Texas Am Investment Managment’s Trades: Q4 2025
Adds
New Buys
Sold Outs
Cuts
4.01ppt
0.75ppt
0.75ppt
0.75ppt
J
Share Count Chg. (%)
Add +1.63%
-1.38ppt
-0.26ppt
0.53ppt
0.59ppt
0.39ppt
0.40ppt
Company Name | Share Count Chg. (%) | Price Paid | Buy Value | Portfolio % Change | |
|---|---|---|---|---|---|
1  AAPL | Add +2219.17% | $268.45 | $27.98M | 4.01ppt | |
2  NVDA | Add +19.96% | $186.14 | $6.04M | 0.75ppt | |
3  JPM | Add +172.29% | $309.60 | $5.12M | 0.75ppt | |
4  AIG | Add +679.60% | $80.02 | $4.94M | 0.75ppt | |
Add +1.63% | $94.16 | $4.12M | -1.38ppt | ||
6  NFLX | Add +798.46% | $107.81 | $4.08M | -0.26ppt | |
7  T | Add +100.00% | $25.32 | $3.80M | 0.53ppt | |
8  BMY | Add +100.00% | $48.11 | $3.70M | 0.59ppt | |
9  COST | Add +1228.46% | $906.18 | $2.89M | 0.39ppt | |
10  HCA | Add +227.53% | $464.28 | $2.74M | 0.40ppt |
University Of Texas/Texas Am Investment Managment’s Holdings: Q4 2025
Company Name | Primary Industry | Avg. price paid  | Share Count Chg. (%) | No of shares held | Market value | Portfolio % Change | % of Ownership | Holding period | Last Transaction | |
|---|---|---|---|---|---|---|---|---|---|---|
- | $94.09 | Add +1.63% | 2.72M | $252.15M | 35.64% -1.38ppt | 26.44% | 18 Quarters | Q4 2025 | ||
2 NVDA | Semiconductors | $109.60 | Add +19.96% | 194.86K | $36.34M | 5.14% 0.75ppt | 0.00% | 13 Quarters | Q4 2025 | |
3 AAPL | Electronic Computers | $269.64 | Add +2219.17% | 108.91K | $29.61M | 4.18% 4.01ppt | 0.00% | 13 Quarters | Q4 2025 | |
4  MSFT | Prepackaged Software | $441.10 | Cut -6.42% | 60.32K | $29.17M | 4.12% -0.71ppt | 0.00% | 10 Quarters | Q4 2025 | |
Computer Programming & Data | $160.12 | Add +0.29% | 80.77K | $25.28M | 3.57% 0.74ppt | 0.00% | 10 Quarters | Q4 2025 | ||
6  AMZN | Retail-Catalog & Mail-Order | $184.00 | Cut -9.88% | 69.95K | $16.15M | 2.28% -0.18ppt | 0.00% | 10 Quarters | Q4 2025 | |
7  META | Computer Programming & Data | $472.54 | Add +4.41% | 17.64K | $11.64M | 1.65% -0.15ppt | 0.00% | 10 Quarters | Q4 2025 | |
8  AVGO | Semiconductors | $167.00 | Cut -13.73% | 32.73K | $11.33M | 1.60% -0.21ppt | 0.00% | 9 Quarters | Q4 2025 | |
9  MA | Other Business Services | $497.56 | Cut -50.87% | 15.12K | $8.63M | 1.22% -1.31ppt | 0.00% | 11 Quarters | Q4 2025 | |
10 JPM | National Banks | $314.93 | Add +172.29% | 26.13K | $8.42M | 1.19% 0.75ppt | 0.00% | 10 Quarters | Q4 2025 | |
11  MS | Security Brokers & Dealers | $177.53 | New Buy +100.00% | 47.20K | $8.38M | 1.18% 1.18ppt | 0.00% | 1 Quarter | Q4 2025 | |
12  TSLA | Motor Vehicle Bodies | $442.76 | Add +9.91% | 17.06K | $7.67M | 1.08% 0.09ppt | 0.00% | 5 Quarters | Q4 2025 | |
13  IMTX | Biological products | $10.61 | 0.00% | 697.43K | $7.32M | 1.04% 0.18ppt | 0.57% | 22 Quarters | Q3 2020 | |
14  XOM | Petroleum Refining | $110.38 | Add +18.45% | 54.64K | $6.58M | 0.93% 0.18ppt | 0.00% | 10 Quarters | Q4 2025 | |
15 AIG | Casualty Insurance | $85.56 | Add +679.60% | 70.85K | $6.06M | 0.86% 0.75ppt | 0.01% | 3 Quarters | Q4 2025 | |
16  MO | Cigarettes | $57.66 | New Buy +100.00% | 104.76K | $6.04M | 0.85% 0.85ppt | 0.01% | 1 Quarter | Q4 2025 | |
17  TXN | Semiconductors | $148.31 | Cut -8.83% | 32.00K | $5.55M | 0.78% -0.15ppt | 0.00% | 25 Quarters | Q4 2025 | |
18  MRK | Pharmaceutical Pres | $88.31 | Add +25.84% | 50.95K | $5.36M | 0.76% 0.27ppt | 0.00% | 2 Quarters | Q4 2025 | |
19 I IVV | - | $587.04 | Cut -8.36% | 7.56K | $5.18M | 0.73% -0.07ppt | 0.00% | 10 Quarters | Q4 2025 | |
20  BAC | National Banks | $42.50 | Cut -48.75% | 91.86K | $5.05M | 0.71% -0.62ppt | 0.00% | 9 Quarters | Q4 2025 |
NEWSLETTER
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersOur content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.